Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise. Sofinnova Partners is a hands-on company builder across the entire value chain of life sciences investments, from seed to later-stage. The firm actively partners with ambitious entrepreneurs as a lead or cornerstone investor to develop transformative innovations that have the potential to positively impact our collective future. Founded in 1972, Sofinnova Partners is a deeply-established venture capital firm in Europe, with 50 years of experience backing over 500 companies and creating market leaders around the globe. Today, Sofinnova Partners has over €2.5 billion under management. For more information, please visit: www.sofinnovapartners.com
240
Total Investments
136
Portfolio Companies
-
Exits
2
Industries
General Information
Company Overview
Investment Criteria
•••••• •••••• ••••••
About Sofinnova Partners
Recent Investments (240)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Series B | •••••• | Aug 2026 | |
| Series C | •••••• | Feb 2026 | |
| Series A | •••••• | Jan 2026 | |
| Series Unknown | •••••• | Nov 2025 | |
| Early VC | •••••• | Nov 2025 | |
|
|
Series C | •••••• | Sep 2025 |
|
|
Series A | •••••• | Jul 2025 |
|
|
Early VC | •••••• | May 2025 |
|
|
Series B | •••••• | May 2025 |
|
|
Post-IPO Equity | •••••• | Mar 2025 |
Latest News
Eu-startups · Sep 28, 2026
Tech · Sep 28, 2026
Eu-startups · Aug 07, 2026
Thenextweb · Jul 02, 2026
France’s Bionyra Pharma launches with €143 million Series A to advance inflammatory disease biologics
Jun 22, 2026
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.